Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02314052 |
| Title | Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Dicerna Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mayo Clinic | Scottsdale | Arizona | 85259-5499 | United States | Details | |
| Massachusetts General Hospital Cancer Center | Boston | Massachusetts | 02114 | United States | Details | |
| South Texas Accelerated Research Therapeutics, LLC | San Antonio | Texas | 78229 | United States | Details | |
| Asan Medical Center | Seoul | 138-736 | Korea, Republic of | Details | ||
| National University Hospital of Singapore | Singapore | 119228 | Singapore | Details | ||
| National Cancer Centre Singapore | Singapore | 169610 | Singapore | Details |